These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 30995069)

  • 21. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.
    Stoll BJ; Hansen NI; Bell EF; Walsh MC; Carlo WA; Shankaran S; Laptook AR; Sánchez PJ; Van Meurs KP; Wyckoff M; Das A; Hale EC; Ball MB; Newman NS; Schibler K; Poindexter BB; Kennedy KA; Cotten CM; Watterberg KL; D'Angio CT; DeMauro SB; Truog WE; Devaskar U; Higgins RD;
    JAMA; 2015 Sep; 314(10):1039-51. PubMed ID: 26348753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; De Jaegere AP; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a physiologic definition on bronchopulmonary dysplasia rates.
    Walsh MC; Yao Q; Gettner P; Hale E; Collins M; Hensman A; Everette R; Peters N; Miller N; Muran G; Auten K; Newman N; Rowan G; Grisby C; Arnell K; Miller L; Ball B; McDavid G;
    Pediatrics; 2004 Nov; 114(5):1305-11. PubMed ID: 15520112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparison of the clinical diagnosis and outcome in preterm infants with bronchopulmonary dysplasia under two different diagnostic criteria].
    Wang CH; Shen XX; Chen MY; Ma XL; Shi LP; Du LZ
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):381-386. PubMed ID: 32392953
    [No Abstract]   [Full Text] [Related]  

  • 27. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
    Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH
    Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small for gestational age very preterm infants present a higher risk of developing bronchopulmonary dysplasia.
    Rocha G; de Lima FF; Machado AP; Guimarães H; Proença E; Carvalho C; Martins LG; Martins T; Freitas A; Dias CP; Silva A; Barroso A; Diogo I; Cassiano G; Ramos H; Abrantes MM; Costa P; Salazar A; Vieira F; Fontes D; Barroso R; Marques T; Santos V; Scortenschi E; Santos C; Vilela F; Quintas C;
    J Neonatal Perinatal Med; 2019; 12(4):419-427. PubMed ID: 31256077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
    Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
    JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
    Trials; 2023 May; 24(1):320. PubMed ID: 37161488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
    Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
    BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants.
    Suresh GK; Davis JM; Soll RF
    Cochrane Database Syst Rev; 2001; 2001(1):CD001968. PubMed ID: 11279743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates].
    Woynarowska M; Rutkowska M; Szamotulska K
    Med Wieku Rozwoj; 2008; 12(4 Pt 1):933-41. PubMed ID: 19471069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Masks versus prongs as interfaces for nasal continuous positive airway pressure in preterm infants.
    Prakash R; De Paoli AG; Oddie SJ; Davis PG; McGuire W
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD015129. PubMed ID: 36374241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchopulmonary dysplasia: Rationale for a pathophysiological rather than treatment based approach to diagnosis.
    Stoecklin B; Simpson SJ; Pillow JJ
    Paediatr Respir Rev; 2019 Nov; 32():91-97. PubMed ID: 30745153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital and Neurodevelopmental Outcomes in Nano-Preterm Infants Receiving Invasive vs Noninvasive Ventilation at Birth.
    Shukla VV; Souder JP; Imbrock G; Hu M; Rahman AKMF; Travers CP; Ambalavanan N; Carlo WA; Lal CV
    JAMA Netw Open; 2022 Aug; 5(8):e2229105. PubMed ID: 36036932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between Intermittent Hypoxemia and Severe Bronchopulmonary Dysplasia in Preterm Infants.
    Jensen EA; Whyte RK; Schmidt B; Bassler D; Vain NE; Roberts RS;
    Am J Respir Crit Care Med; 2021 Nov; 204(10):1192-1199. PubMed ID: 34428130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.